MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image TELAVANT HOLDINGS
TELAVANT HOLDINGS

TELAVANT HOLDINGS

Summary

Telavant is developing innovative therapies to help patients living with inflammatory and fibrotic diseases.

Deals Overview

Total Deals1
Valued Deals1
Total Value£ 5.96 B
Avg. Deal Size£ 5.96 B

Market Context

Sort

23 Oct 2023|United States|Biotechnology
Telavant Holdings
Roche Holdings

Target: TELAVANT HOLDINGS

Bidder: ROCHE HOLDINGS AG

8 Service Providers

1 Target | 3 Bidder | 4 Vendor

32 Dealmakers

2 Target | 2 Bidder | 28 Vendor

£ 5.96 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite